Literature DB >> 28039692

Biological characteristics of CCN proteins in tumor development.

Stephany C Barreto1, Amitabha Ray, Page Ag Edgar.   

Abstract

The extracellular membrane (ECM) is no longer regarded as inert, rather it has multiple versatile physiologic functions. Its diverse composition is implicated in each step of cancer progression including inflammation, angiogenesis, tumor invasion and metastasis. In addition to structural proteins, the ECM also contains a family of non-structural proteins called matricellular proteins. The six secreted CCN proteins, which belong to the matricellular protein family, include the following: Cyr61 (CCN1), CTGF (CCN2), Nov (CCN3), WISP- 1 (CCN4), WISP-2 (CCN5) and WISP-3(CCN6). These proteins are capable of modulating a variety of biological processes in health as well as in disease conditions. In tumor development and in tumor microenvironment, CCN proteins can influence multiple facets of pathophysiological processes including cellular proliferation, invasion and metastasis. This review has attempted a cohesive look at the CCN family protein functions in a tumor-specific manner.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28039692

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  15 in total

1.  Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease.

Authors:  Wenconghui Wu; Xingjian Hu; Xianming Zhou; Philip A Klenotic; Qi Zhou; Zhiyong Lin
Journal:  J Cell Commun Signal       Date:  2017-12-06       Impact factor: 5.782

2.  Novel treatment avenues for uterine leiomyoma: a new implication for endothelin?

Authors:  Kedra Wallace; Krystal Chatman; Venessia Johnson; Alexis Brookins; John Rushing; Babbette LaMarca
Journal:  Clin Sci (Lond)       Date:  2018-10-29       Impact factor: 6.124

3.  Hypomethylation of CTGF Promoter in Placenta and Peripheral Blood of Pre-eclampsia Women.

Authors:  Lu Zhang; Fei Zhao; Cuncun Yang; Qian Tang; Ru Zhang; Jing Li; Aiping Chen; Lin Hou; Shiguo Liu
Journal:  Reprod Sci       Date:  2020-02-03       Impact factor: 3.060

4.  Advanced glycation end products promote VEGF expression and thus choroidal neovascularization via Cyr61-PI3K/AKT signaling pathway.

Authors:  Lijuan Sun; Tonglie Huang; Wenqin Xu; Jiaxing Sun; Yang Lv; Yusheng Wang
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

5.  Fluvastatin inhibits advanced glycation end products-induced proliferation, migration, and extracellular matrix accumulation in vascular smooth muscle cells by targeting connective tissue growth factor.

Authors:  Ae-Rang Hwang; Ju-Ock Nam; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2018-02-23       Impact factor: 2.016

6.  WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells.

Authors:  Zi-Qing Shi; Zi-Yan Chen; Yao Han; Heng-Yan Zhu; Meng-Dan Lyu; Han Zhang; Yi Zhang; Liu-Qing Yang; Wei-Wei Pan
Journal:  J Ovarian Res       Date:  2020-07-25       Impact factor: 4.234

7.  CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.

Authors:  Huey-En Tzeng; Chih-Hsin Tang; Sz-Hua Wu; Hsien-Te Chen; Yi-Chin Fong; Yung-Chang Lu; Wei-Cheng Chen; Hsien-Da Huang; Chih-Yang Lin; Shih-Wei Wang
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 8.  The role of CCN4/WISP-1 in the cancerous phenotype.

Authors:  Mary P Nivison; Kathryn E Meier
Journal:  Cancer Manag Res       Date:  2018-08-27       Impact factor: 3.989

9.  Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer.

Authors:  Yuhong Sun; Xuefei Bao; Yong Ren; Lina Jia; Shenglan Zou; Jian Han; Mengyue Zhao; Mei Han; Hong Li; Qixiang Hua; Yi Fang; Jingyu Yang; Chunfu Wu; Guoliang Chen; Lihui Wang
Journal:  Cell Death Dis       Date:  2019-05-24       Impact factor: 8.469

Review 10.  Cellular communication network factor 3 in cartilage development and maintenance.

Authors:  Satoshi Kubota; Harumi Kawaki; Bernard Perbal; Kazumi Kawata; Takako Hattori; Takashi Nishida
Journal:  J Cell Commun Signal       Date:  2021-06-14       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.